Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 March 2024 .Powered by Capital Market - Live News

Net Loss of Vista Pharmaceuticals reported to Rs 1.63 crore in the quarter ended December 2023 as against net loss of Rs 0.96 crore during the previous quarter ended December 2022. Sales reported to Rs 1.70 crore in the quarter ended December 2023. There were no Sales reported during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1.700 0 OPM %-102.350 - PBDT-2.02-0.74 -173 PBT-2.20-0.89 -147 NP-1.63-0.96 -70 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 February 2024. The meeting would commence at 4.30 pm.Powered by Capital Market - Live News

Net Loss of Vista Pharmaceuticals reported to Rs 2.02 crore in the quarter ended September 2023 as against net loss of Rs 0.24 crore during the previous quarter ended September 2022. Sales reported to Rs 3.47 crore in the quarter ended September 2023. There were no Sales reported during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales3.470 0 OPM %-33.720 - PBDT-1.41-0.41 -244 PBT-1.59-0.56 -184 NP-2.02-0.24 -742 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 November 2023.Powered by Capital Market - Live News